Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stemtech HealthSciences India is the Indian subsidiary of Stemtech Corporation, a global leader in the stem cell nutrition industry. The company specializes in the development and distribution of botanical-based dietary supplements that aim to support the natural release of adult stem cells from the bone marrow. Its product line, including SE2 and StemFlo, is marketed through a direct-selling network across India to promote cellular health and general wellness. Unlike traditional biotechnology firms, Stemtech focuses on nutraceutical solutions and does not maintain a clinical drug development pipeline. The company serves a broad consumer base interested in anti-aging and regenerative health through natural supplementation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stemtech HealthSciences India.